Third Rock Ventures V, L.P. - 10%+ Owner at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
RAPP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Third Rock Ventures V, L.P. since 31 Jan 2025

Holdings reported by Third Rock Ventures V, L.P. for Rapport Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,135,233 $71,209,625 $9.98 10 Jun 2024 Direct
Common Stock 969,218 $9,672,796 $9.98 10 Jun 2024 By Third Rock Ventures VI, L.P.
Series A Preferred Stock 0 10 Jun 2024 By Third Rock Ventures VI, L.P. Common Stock
Series A Preferred Stock 0 10 Jun 2024 Direct Common Stock
Series B Preferred Stock 0 10 Jun 2024 By Third Rock Ventures VI, L.P. Common Stock

Transactions reported by Third Rock Ventures V, L.P. for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.